ArticleFrontiers in immunology2020

Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort.

Ankit K Desai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.